Results 131 to 140 of about 1,528,518 (167)
Some of the next articles are maybe not open access.
[High Dose Rate 192Ir-Microselectron].
Ugeskrift for laeger, 1990The HDR 192Ir-Microselectron is a new high-dose-rate remote afterloading apparatus using a small 192Ir source with very high activity, 370 GBq (10 Ci). The size of the source permits treatment through catheters with diameters as small as 1.9 mm. This makes it possible to give endobronchial treatment to lung-cancer patients through a fibrebronchoscope ...
J K, Bentzen +2 more
openaire +1 more source
[High dose rate prostate brachytherapy].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2013This article aims at presenting the interest of high dose rate brachytherapy in the radiation treatment of prostatic adenocarcinoma. We will discuss successively the biological and dosimetric specificity of brachytherapy for this particular cancer. Afterwards, we will review the main phase II and III studies, the therapeutic indications in the daily ...
P, Nickers +5 more
openaire +1 more source
High dose rate versus low dose rate brachytherapy for gynecological cancer
Seminars in Radiation Oncology, 1993High dose rate (HDR) remote afterloading for the treatment of gynecologic cancers began about 30 years ago. The promising clinical results obtained have led to the establishment of hundreds of HDR facilities worldwide with tens of thousands of patients treated.
openaire +1 more source
International Journal of Radiation Oncology*Biology*Physics, 2003
Daniel G. Petereit, Jack F. Fowler
openaire +1 more source
Daniel G. Petereit, Jack F. Fowler
openaire +1 more source
[Brachytherapy for prostate cancer: high dose rate or low-dose rate?].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2006Low-dose brachytherapy for prostate cancer was actually proposed in the first years of the XXth century. Its modern version (iodin 125 or palladium 103 permanent implants) now benefits from some 15 years of experience in a few pioneer centers, with very satisfactory results in term of efficacy/toxicity ratio.
J-M, Cosset, C, Haie-Meder
openaire +1 more source
Remote controlled high dose rate brachytherapy
Critical Reviews in Oncology/Hematology, 1996S, Nag, C, Orton, B, Thomadsen
openaire +2 more sources
Current treatment and future directions in the management of anal cancer
Ca-A Cancer Journal for Clinicians, 2022Leila T Tchelebi +2 more
exaly